Wealth Alliance Gsk PLC Transaction History

Wealth Alliance

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$34.07 - $39.94 $491,493 - $576,174	-14,426 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$38.11 - $42.99 $53,430 - $60,271	-1,402 Reduced 8.86%	14,426 $543,000
Q2 2020 Aug 14, 2020	BUY	$37.87 - $43.58 $69,491 - $79,969	1,835 Added 13.11%	15,828 $646,000
Q1 2020 May 15, 2020	SELL	$32.47 - $48.83 $159,525 - $239,901	-4,913 Reduced 25.99%	13,993 $530,000
Q4 2019 Feb 14, 2020	BUY	$42.0 - $48.25 $756,756 - $869,368	18,018 Added 2029.05%	18,906 $888,000
Q4 2019 Feb 12, 2020	BUY	$42.0 - $48.25 $37,296 - $42,846	888 New	888 $888,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.4B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Wealth Alliance, based on Form 13F filings with the SEC.

Stay updated on Wealth Alliance with notifications on news.